Dr. Reddy's Labs Files 6-K, Reports Under Form 20-F
Ticker: RDY · Form: 6-K · Filed: Aug 29, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, compliance, foreign-private-issuer
Related Tickers: RDY
TL;DR
RDY filed a 6-K, confirming 20-F reporting. Standard compliance update.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on August 29, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its annual reports under Form 20-F. The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, India.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' compliance with SEC reporting requirements for foreign private issuers, providing transparency to investors regarding its financial reporting structure.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and not indicating any new material events or financial changes.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana, India (location) — Principal executive office address
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report information as a foreign private issuer, specifically confirming that the registrant files its annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on August 29, 2025.
What is the principal executive office address of Dr. Reddy's Laboratories Limited?
The principal executive office address is 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, 500 034, India.
Under which SEC Act is this filing made?
This filing is made pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Does Dr. Reddy's Laboratories Limited file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Limited indicates it files annual reports under cover of Form 20-F.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-08-29 06:44:47
Filing Documents
- rdy0796_6k.htm (6-K) — 47KB
- rdy0796_ex99-1.htm (EX-99.1) — 75KB
- rdy0796_ex99-1img01.jpg (GRAPHIC) — 11KB
- rdy0796_ex99-1img02.jpg (GRAPHIC) — 7KB
- rdy0796_ex99-1img03.jpg (GRAPHIC) — 9KB
- 0001575872-25-000553.txt ( ) — 161KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: August 29, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3